SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-04-085757
Filing Date
2004-05-12
Accepted
2004-05-12 10:51:36
Documents
2
Period of Report
2004-06-22
Effectiveness Date
2004-05-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 307712
2 GRAPHIC g72642g74k82.jpg GRAPHIC 75386
  Complete submission text file 0001193125-04-085757.txt   384982
Mailing Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341
Business Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341 610-458-6200
ANTARES PHARMA INC (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: MN | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-20945 | Film No.: 04798006
SIC: 3841 Surgical & Medical Instruments & Apparatus